Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Recurrent cold sores - herpes simplex labialis (HSL) occurs in 20-40% of the US population
and patient seek treatment because of the discomfort and visibility of the lesion although it
is a self limiting disease. The purpose of this study is to check the safety, Efficacy and
convenience of Use of the Natural Agent "Superlysin Gel" as Treatment for Herpes Labialis in
Comparison to Acyclovir 5% and Docozanole 10%.